SITC Cancer Immunotherapy CONNECT

Browse our other events

SITC Drug Development Summit

SITC Summit on Intralesional Immunotherapy: Moving Beyond Oncolytic Viruses

Thursday, Sept. 19, 2024 - 11 a.m.–3:15 p.m. EDT

This open-door virtual event will present the current state and future directions of the field and feature participation of invited stakeholders involved in intralesional immunotherapy research and development.

REGISTER Now

SITC Drug Development Summit

SITC Immuno-oncology Drug Development Summit

Sept. 30 – Oct. 1, 2024 in Boston at The Revere Hotel Boston Common

The SITC Immuno-oncology Drug Development Summit will ensure that active, innovative new therapies are rapidly and appropriately moved into clinical testing.

Learn More
Immunotherapy

Advances in Cancer Immunotherapy™ (ACI) Series

ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI's offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics. ACI webinars are FREE for healthcare professionals, students, patients and patient advocates.

Explore the 2024 ACI Series
Glyco-Immunology Webinar

2024 Glyco-Immunology Webinar Series

Presented by SITC and the Society for Glycobiology, this FREE webinar series will address the impact of glycobiology on immune regulation, anti-tumor immunity, and immune resistance. Develop more effective cancer immunotherapies by applying principles of glyco-immunology.

EXPLORE SERIES

ACI Hematologic

Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies

Wednesday, Sept. 11 |1–5 p.m. ET 
Virtual – Zoom

Program addresses how to identify and manage CAR T -associated secondary malignancies. FREE for healthcare professionals, students, patients and patient advocates.

Register
ACI Radiation Oncology

Advances in Cancer Immunotherapy™: A Focus on Radiation Oncology

Sunday, Sept. 29 |2:30–4:30 p.m. ET 
Live at ASTRO 2024

Gain an understanding of the current status of knowledge of the mechanisms of action of combinations of immunotherapeutic agents and radiation that can inform treatment decisions.

LEARN MORE
ImmunoRad 2024

Primer on Radiation Therapy-Induced Modulation of the TME

Thursday, Oct. 3 | 10:30 a.m.–12:30 p.m. ET | Live at ImmunoRad 2024

Understand novel strategies to address checkpoint resistance with the SITC and Weill Cornell Medicine Primer on Radiation Therapy-Induced Modulation of the TME. 

VIEW DETAILS
ACI Intratumoral Therapies, Vaccines and Cytokines

Advances in Cancer Immunotherapy™: A Focus on Intratumoral Therapies, Vaccines, & Cytokines

Wednesday, Oct. 9 |11 a.m.–3 p.m. ET Virtual – Zoom

Program features a session on emerging therapies, where the EMERALD trial and FLASH radiotherapy plan to be discussed. 

Explore Program
ACI Pathology

Advances in Cancer Immunotherapy™: A Focus on Pathology

Tuesday, Dec. 10 |11 a.m.–3 p.m. ET Virtual – Zoom

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of the clinical implementation of immuno-oncology pathology.

REGISTER
2025 Winter School

2025 Cancer Immunotherapy Winter School

February 11–14, 2025 in Austin, TX
and Virtually

Explore the core principles of tumor immunology and cancer immunotherapy, including biomarker technology, validation and clinical integration, clinical trial design, data analysis and considerations for combination therapies.

Register Today

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

 Upcoming SITC Events

 Read the Latest SITC News

This webinar on August 15th examined how immune checkpoint inhibitors are being utilized around ...

JITC Digest August 2024

INSIDE THIS ISSUE: Letter from the Editor | JITC Editor Picks ...
The following articles have been recommended for further reading in the field of cancer immunotherapy ...

 Latest Discussions

  • Hello! SITC is pleased to host two Virtual Summits in the upcoming months! ...

  • Hello! Attached is a flyer for the SITC Summit on Intralesional Immunotherapy: ...

  • Hello! Attached is a flyer for the SITC Summit on Immunomodulation ...

    1 person likes this.

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

 Join the SITC Family